Literature DB >> 7604874

Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice. An autoradiographic, immunohistological, and direct fluorescence microscopy study.

F Plenat1, N Klein-Monhoven, B Marie, J M Vignaud, A Duprez.   

Abstract

Antisense oligonucleotides have the ability to inhibit individual gene expression in the potential treatment of cancer and viral diseases. However, the way parenterally administered oligonucleotides distribute themselves into healthy tissues or tumors is poorly understood. In this study, the cell and tissue distribution of two modified or unmodified phosphodiester pentadeca-beta-oligonucleotides intravenously administered to healthy or tumor-bearing nude mice was assessed by autoradiography as well as by direct fluorescence and immunoenzymatic histological methods. Resistance of oligonucleotides to degradation by nuclease activity was previously studied in vitro. Using these methods we were able to show the following: 1) within minutes, oligonucleotides permeate all cells and tissues with the exceptions of erythrocytes and intervertebral discs; 2) cell and tissue distribution does not depend on the sequence of the given oligonucleotide; 3) concentration of oligonucleotides is higher within the connective tissue cells than in the interstitial matrix; 4) after uptake, oligomers partition throughout all of the cellular compartments, including at the highest intracellular concentrations in the nuclei; 5) oligonucleotides penetrate easily the tumor cell compartments, oligonucleotide diffusion being unimpeded by the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7604874      PMCID: PMC1869869     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

Review 1.  Immunohistochemical methods for studying mononuclear phagocytes in tissue sections.

Authors:  F Plenat; Y Martinet; N Martinet; J M Vignaud
Journal:  J Immunol Methods       Date:  1994-09-14       Impact factor: 2.303

2.  Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA.

Authors:  W Emlen; M Mannik
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

Review 3.  A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy.

Authors:  D M Tidd
Journal:  Anticancer Res       Date:  1990 Sep-Oct       Impact factor: 2.480

4.  Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

Authors:  L A Yakubov; E A Deeva; V F Zarytova; E M Ivanova; A S Ryte; L V Yurchenko; V V Vlassov
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  [Man-nude mouse tissue chimera: characterization of cell population by in situ hybridization].

Authors:  F Plenat; A Duprez
Journal:  C R Acad Sci III       Date:  1989

6.  Characterization of oligonucleotide transport into living cells.

Authors:  S L Loke; C A Stein; X H Zhang; K Mori; M Nakanishi; C Subasinghe; J S Cohen; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 7.  Oligodeoxynucleotides as inhibitors of gene expression: a review.

Authors:  C A Stein; J S Cohen
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

8.  alpha-Oligodeoxynucleotide stability in serum, subcellular extracts and culture media.

Authors:  T A Bacon; F Morvan; B Rayner; J L Imbach; E Wickstrom
Journal:  J Biochem Biophys Methods       Date:  1988-08

9.  The interstitial matrix of human carcinomas and sarcomas transplanted to the nude mouse: immunolocalization of some human and murine components.

Authors:  A Duprez; S Guerret; J M Vignaud; F Plenat; D Hartmann; J A Grimaud
Journal:  Cell Mol Biol       Date:  1987       Impact factor: 1.770

10.  Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups.

Authors:  D M Tidd; H M Warenius
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

View more
  5 in total

1.  Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice.

Authors:  A Rifai; W Brysch; K Fadden; J Clark; K H Schlingensiepen
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

2.  Depletion of telomerase RNA inhibits growth of gastrointestinal tumors transplanted in mice.

Authors:  Xue-Cheng Sun; Jing-Yi Yan; Xiao-Lei Chen; Ying-Peng Huang; Xian Shen; Xiao-Hua Ye
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 3.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

4.  Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic.

Authors:  Pedro M D Moreno; Ana P Pêgo
Journal:  Front Chem       Date:  2014-10-14       Impact factor: 5.221

Review 5.  Antisense oligonucleotide therapy for urologic tumors.

Authors:  Ingo Kausch; Andreas Böhle
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.